Latest Share Placements News

Decidr AI Industries moves to acquire full ownership of Decidr.ai, launches its unified AI platform DecidrOS, and reports robust Q1 FY26 progress with significant capital raising and expanding partnerships.

Scalare Partners has bolstered its founder support ecosystem through the acquisitions of Tank Stream Labs and Planet Startup, already driving significant revenue growth and expanding its national footprint.

S2 Resources has agreed to sell its Fosterville exploration licence to Agnico Eagle for A$17 million and raised an additional A$3 million through a strategic share placement, positioning the company strongly for future exploration.

Holista Colltech has raised $2.295 million through a share placement to two international investors, aiming to bolster its operations and balance sheet. The move highlights the company’s ongoing efforts to support growth across its health and wellness divisions.

Unith Ltd reports a 32% rise in Q1 FY26 cash receipts and unveils its breakthrough Streaming Avatars technology, alongside a successful $1.85 million capital raise.

Estrella Resources has reported significant high-grade manganese intersections at its Ira Miri project and initiated a major limestone drilling campaign at Werumata, marking a pivotal quarter in its Timor-Leste exploration efforts.

Tungsten Mining NL reports strong progress on its Mt Mulgine Project, leveraging soaring tungsten prices and a new gold resource estimate to drive development. The company also raises $9.5 million and initiates a US OTCQB listing process.

Kalamazoo Resources retains full ownership of its Ashburton Gold Project after Northern Star declines its acquisition option, accelerating a Scoping Study supported by record gold prices. The company also expands its footprint with the strategic Xanadu acquisition and secures $2 million in fresh capital.

Mindax Limited has taken a decisive step toward full ownership of the Mt Forrest iron ore project, executing an option to acquire Norton Gold Fields' stake and raising $1.6 million to accelerate development. The company is also advancing infrastructure plans and gold exploration in Western Australia’s Mid-West region.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Star Minerals has raised $1.5 million through a share placement to fund critical drilling and mining approvals at its Tumblegum South Gold Project, aiming for production start in early 2026.

Ballard Mining has raised $20.6 million through a premium share placement led by new strategic investor Aurenne Group Holdings, aiming to accelerate exploration and resource growth at its Mt Ida Gold Project. A new, substantial October 2025 Exploration Target highlights significant upside beyond the existing mineral resources.